具身智能公司帕西尼完成新一輪A輪融資 京東(09618.HK)戰略領投
內地具身智能整機及傳感器企業帕西尼完成新一輪A輪融資,由京東(09618.HK)戰略領投,浦耀信曄、宏兆基金、張科垚坤等多間公司跟投,庚辛資本中國擔任獨家戰略財務顧問。4個月內,帕西尼已獲10億元人民幣投資額。
金
帕西尼亦是京東近3個月投資的第6間具身智能相關企業。從5月至今,京東已經宣布投資智元機器人、千尋智能、逐際動力、眾擎機器人、RoboScience等,投資已覆蓋具身智能全產業鏈,包括機器人本體、核心零部件、運動控制技術、具身模型、交互大模型等領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.